Helio Vision

Helio Vision, Founded in 2016, Develops a Drug for Treating Rare Fibroproliferative Diseases That Cause Abnormal Scarring and Blindness After Retinal Surgery. Helio Vision's Solutions Have Achieved Breakthrough Progress in Preventing Blindness, Reducing Reoperation Costs, and Improving Patients' Quality of Life.